Table 1. Detected peaks used to generate cross-validated classification models between different groups.

GroupComparisons	Mass-to-charge ratio(m/z)	CrossValidation (%)	RecognitionCapacity (%)
Control versus CRC	6037.33 1347.15 5753.37	95.94	98.96
	1530.03 3192.32
Control versus ACA	4054.72 2365.93 1529.99	100.00	100.00
	2660.35 2021.19
ACA versus CRC	4644.29 6088.98 1074.23	98.19	100.00
	4963.96 4248.41

CRC = colorectal cancer; ACA = advanced colorectal adenoma; Cross Validation and Recognition Capacity were calculated from GA.